MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α

Treatment Options in Hepatocellular Carcinoma Today

(2017) T. Livraghi et al.   Scandinavian Journal of Surgery

miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a

(2013) Xin Chen et al.   FEBS LETTERS

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma

(2013) Yingjian Liang et al.   HEPATOLOGY

MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma

(2013) Kyu Yeoun Won et al.   HUMAN PATHOLOGY

MicroRNA-338-3p Inhibits Colorectal Carcinoma Cell Invasion and Migration by Targeting Smoothened

(2013) Q. Xue et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP

(2013) Pu Li et al.   PLoS One

Sorafenib Inhibits Hypoxia-Inducible Factor-1  Synthesis: Implications for Antiangiogenic Activity in Hepatocellular Carcinoma

(2012) L.-p. Liu et al.   CLINICAL CANCER RESEARCH

miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3′-UTR Region of CyclinD1

(2012) Xiaoyu Fu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors

(2012) ChengShi Chen et al.   TUMOR BIOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hypoxia-Inducible Factor-1α Downregulation by Small Interfering RNA Inhibits Proliferation, Induces Apoptosis, and Enhances Radiosensitivity in Chemical Hypoxic Human Hepatoma SMMC-7721 Cells

(2011) Wei Yang et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Hypoxia and hypoxia inducible factors: Diverse roles in liver diseases

(2011) Bharath Nath et al.   HEPATOLOGY

Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?

(2011) Uzma Asghar et al.   JOURNAL OF HEPATOLOGY

miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened

(2011) Xiao-Hui Huang et al.   JOURNAL OF PATHOLOGY

Double-Transduced MDCKII Cells To Study Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Interplay in Drug Transport across the Blood−Brain Barrier

(2011) Birk Poller et al.   MOLECULAR PHARMACEUTICS

Hepatocellular Carcinoma

(2011) Hashem B. El-Serag   NEW ENGLAND JOURNAL OF MEDICINE

Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells

(2010) Eunyoung Tak et al.   JOURNAL OF HEPATOLOGY

Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease

(2010) Olivier Rosmorduc et al.   SEMINARS IN LIVER DISEASE

Accurate microRNA target prediction correlates with protein repression levels

(2009) Manolis Maragkakis et al.   BMC BIOINFORMATICS

DIANA-microT web server: elucidating microRNA functions through target prediction

(2009) M. Maragkakis et al.   NUCLEIC ACIDS RESEARCH

Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer

(2008) Mohd W. Nasser et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1

(2008) Tyler E. Miller et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a)

(2008) B. M. Emerling et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA